Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020

Rhea-AI Summary

Adamas Pharmaceuticals (Nasdaq: ADMS) will report its Q3 2020 financial results on November 5, 2020, after market close. Following the financial report, a conference call will be held at 4:30 PM ET to discuss results and provide corporate updates. Investors can access the call by dialing (844) 215-3280 (U.S.) or (484) 747-6383 (international) using Conference ID: 1578986. A live webcast will be available on the Adamas website and will be accessible for replay until December 5, 2020.

EMERYVILLE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2020 third quarter financial results on Thursday, November 5, 2020, after market close. Subsequently, Adamas’ management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update.

Investor Conference Call and Webcast
The conference call can be accessed by dialing (844) 215-3280 for participants in the U.S. or Canada and (484) 747-6383 for international callers. All callers must provide the following Conference ID: 1578986. The webcast can be accessed live via the investor section of the Adamas website at https://ir.adamaspharma.com/events-presentations and will be available for replay until December 5, 2020.

About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Contact

Media: Sarah Mathieson Vice President, Corporate Communications 510-450-3528 smathieson@adamaspharma.com

Investors: Peter Vozzo Managing Director, Westwicke 443-213-0505 peter.vozzo@westwicke.com

FAQ

When will Adamas Pharmaceuticals report its Q3 2020 financial results?

Adamas Pharmaceuticals will report its Q3 2020 financial results on November 5, 2020, after market close.

How can I access the Adamas Pharmaceuticals conference call?

The conference call can be accessed by dialing (844) 215-3280 for U.S. participants or (484) 747-6383 for international callers, using Conference ID: 1578986.

What time is the Adamas Pharmaceuticals conference call scheduled for?

The conference call is scheduled for 4:30 PM Eastern Time on November 5, 2020.

Is there a replay available for the Adamas Pharmaceuticals conference call?

Yes, the conference call will be available for replay until December 5, 2020.

Where can I find more information about Adamas Pharmaceuticals?

More information about Adamas Pharmaceuticals can be found on their website at www.adamaspharma.com.